Injection drug issue puts US execution on hold
Controversy over a lethal injection drug imported from India on Wednesday led Nebraska's Supreme Court to put on hold the execution of a convicted killer.
bdnews24.com News Service
bdnews24.com
Published :
27 May 2011, 04:46 AM
Updated :
10 Aug 2022, 04:52 PM
OMAHA, Neb, May 27 (bdnews24.com/Reuters) - Controversy over a lethal injection drug imported from India on Wednesday led Nebraska's Supreme Court to put on hold the execution of a convicted killer.
Carey Dean Moore had been scheduled to be executed June 14 in Lincoln, where he has been on the state's death row for more than 30 years, but his lawyers appealed over one of the three drugs the state planned to use in his lethal injection.
Nebraska prison officials had purchased that drug, sodium thiopental, from a company in Mumbai after being unable to find a domestic supplier.
Moore's attorney, Jerry Soucie, argued that the company, Kayem Pharmaceutical Pvt., Ltd., is not approved or regulated by the US government, thus the sodium thiopental could be faulty and lead to a botched execution.
The Nebraska Supreme Court issued a stay of Moore's execution so that the appeal can be heard by a lower court.
"First and foremost is the fact that this company has never been registered or inspected by any US government agency, including the Drug Enforcement Agency or the Food and Drug Administration," Soucie said. "That (registration and inspection) is a requirement of US law."
Sodium thiopental is a sedative and the first in a sequence of three drugs administered in lethal injections to paralyze breathing and stop the heart. A sedative is required in all lethal injections of all US death row inmates.
State corrections departments have been scrambling to find supplies of the drug since a US manufacturer, Hospira Inc stopped making the drug earlier this year.
The FDA began allowing imports of sodium thiopental for lethal injection without separately approving the import versions. Moore, who was convicted in the 1979 execution-style slayings of two Omaha taxi drivers, is one of a number of death-row inmates who have challenged this in lawsuits.
Several foreign governments, including Italy and Britain, are prohibiting export of the drug for use in executions. And Kayem Pharmaceutical, the company cited in the Nebraska case, in April said it stopped selling the drug for use in capital punishment because that goes against the "the ethos of Hinduism."
In the wake of the shortage, Ohio last month executed a man convicted for murder using an animal euthanasia drug, known as pentobarbital. Britain has banned the export of three drugs used in lethal injections to the United States.
The Nebraska State Attorney General's Office issued a statement saying it was reviewing its options after the Supreme Court issued the stay in the Moore case.
bdnews24.com/cr/1046h.